They’re talking about us in the press!
Thank you to Sciences et Avenir and to Lenaïg Corderoc’h for the fine article published following the visit to our site in Grenoble.
The article entitled ‘Spotlight on Parkinson’s disease, a medical device implanted in the patient’s head’ presents the NIR (Near InfraRed) research project being carried out at Clinatec with the aim of treating Parkinson’s disease.
A new visual identity for the Fonds Clinatec
The year 2023 was a busy one for the Fonds Clinatec, with the arrival of a new CEO, Dr Laurent Hérault, a new President, Sophie Cluzel, and a Scientific Director, Prof. John Mitrofanis. As we approach our 10th anniversary, these changes reflect an evolution in the ambition of the Fonds Clinatec, which has adopted a […]
Kevin Paul, Fonds Clinatec talent for November
With two Masters degrees in Pharmaceutical Sciences and Physiology, Neuroscience and Behavior, Kevin joined the Fonds Clinatec in September 2023 to prepare a thesis in Neuroscience. His research project is part of the KLESIA SomniBrain project, which aims to use photobiomodulation to treat sleep disorders in Parkinson’s disease patients.
Scientific paper
Congratulations to Dr Jaimie Hoh Kam and Prof. John Mitrofanis who has recently published in Cells MDPI Journal, on the impact of glucose on modifying ATP and ROS levels in mouse fibroblast cell cultures by #photobiomodulation. This work was carried out as part of the major #CoveaNeurotec program on the #detection, #treatment and #prevention of […]